Belle Mead, NJ, United States of America

Anurag S Srivastava

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 7.4

ph-index = 4

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2007-2022

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Anurag S Srivastava: Innovator in Pharmaceutical Chemistry

Introduction

Anurag S Srivastava is a prominent inventor based in Belle Mead, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific enzymes and diseases. With a total of 12 patents to his name, Srivastava's work is recognized for its potential impact on treating various medical conditions.

Latest Patents

Among his latest patents, Srivastava has developed indole and azaindole inhibitors of PAD enzymes. This invention provides compounds that are useful as inhibitors of PAD4, along with methods for treating PAD4-related disorders. Another notable patent involves substituted tetrahydrocarbazole and carbazole carboxamide compounds. These compounds are designed to inhibit Bruton's tyrosine kinase (Btk) and are applicable in treating autoimmune diseases and vascular diseases.

Career Highlights

Anurag S Srivastava is currently associated with Bristol-Myers Squibb Company, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing therapeutic options for patients suffering from complex diseases.

Collaborations

Throughout his career, Srivastava has collaborated with esteemed colleagues, including Douglas G Batt and Soo Sung Ko. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.

Conclusion

Anurag S Srivastava's contributions to pharmaceutical chemistry exemplify the importance of innovation in medicine. His patents reflect a commitment to addressing critical health challenges through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…